We are monitoring the impact of COVID-19 on Biochips Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1550
Share on
Share on

Global Biochips Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Type, End User and Region – Industry Forecast (2021 to 2026)

Pulished: February, 2020
ID: 1550
Pages: 178

Global Biochips Market Size (2021 to 2026)

As per our report, the global biochips market size is estimated at a global level at USD 15.76 billion in 2021. This value is forecasted to be growing at a CAGR of 22.2% to reach USD 42.96 billion by 2026.

Biochips are increasingly being adopted in different applications in genomics, drug discovery, and proteomics in the current market scenario. Besides, the development of targeted and personalized medicines for cancer treatment and advances in biochip technology also supports the growth of biochip products.

MARKET DRIVERS:

The adoption of biochips is increasing in various applications in genomics, proteomics, and drug discovery. The advancement of targeted and personalized medicines for the treatment of cancer is influencing the market growth. An increase in cancer prevalence, immunological disorders, and viral infections is boosting the market growth.

Other factors such as the rising number of biochips applications, technological advancement in biochips, and improving infrastructure facilities are leveling up the biochips market demand. Moreover, rising funds by government and private organizations in the emerging nations are expected to provide better opportunities for the market players. Escalating healthcare expenditure and growing awareness over the benefits of early diagnosis are likely to fuel the growth rate of the market.

Additionally, aspects such as growing cancer prevalence, rising incidence of viral infections and immunological disorders, increasing geriatric population, rapidly increasing biochip applications, and increasing acceptance of personalized medicine may serve as significant global biochip market growth drivers. Technological advances and high investment in R&D would act as an opportunity for biochips market players.

MARKET RESTRAINTS:

The factors such as higher cost biochips and lack of knowledge about biochips are hampering the market growth. Moreover, a lack of awareness among the people about biochips technologies is primarily restricting biochips market growth.

Impact of covid-19 on the global biochips market:

COVID 19 pandemic is a boom for the growth of the biochips market. Biochips have relevance in detecting the COVID 19. This factor has led to market shares during the outbreak. Market players focus on launching various products using biochips technology, which helped the healthcare providers in these tough times. Also, with the surging cases of the COVID 19, there is a high prevalence to develop a vaccine where the researchers need to study the effects of coronavirus on the human body. Biochips play a major role in enabling the assessment of patient response, including antibody response, which helps the researchers understand the sequences in developing a vaccine.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Analysed

By Type, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This research report on the global biochips market has been segmented and sub-segmented based on the type, end-user, and region.

Biochips Market – By Type:

  • DNA Chips
    • SNP Genotyping
    • Genomics
    • Agricultural Biotechnology
    • Gene Expression
    • Cancer Diagnosis & Treatment
    • Drug Discovery
    • Others
  • Lab-On-A-Chip
    • Clinical Diagnostics
    • IVD & POC
    • Drug Discovery
    • Genomics
    • Proteomics
  • Protein Chips
    • Expression Profiling
    • High-Throughput Screening
    • Proteomics
    • Diagnostics
    • Drug Discovery

Based on type, DNA Chips are the largest segment, followed by lab-on-chips and protein biochips market, due to development in the proteomics and genomics field. However, enhancement in the area of recombinant proteins would assist the growth of the protein biochips market.

Biochips Market – By End User:

  • Hospitals and Diagnostic Centres
  • Biotechnology and Pharmaceutical Companies
  • Academic & Research Institutes

Based on end-user, the Hospitals and Diagnostics Centre segment dominates the market, as it is primarily driven by various factors such as increasing government funding and technological advancements.

Biochips Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, the most significant chunk of this market is North America, followed by Europe. Variables such as an aging population and a growing prevalence of lifestyle diseases and cardiac abnormalities are vital factors for the growth of the biochip market in North America.

On the other hand, throughout the forecast period, the Asia Pacific market is expected to expand at the highest CAGR. Rapid growth in the life sciences sector in China and India, an increase in biotechnology and pharmaceutical research, and low infrastructure costs are among the key factors driving growth in the Asian biochip market.

KEY MARKET PLAYERS:

Companies leading the global biochips market profiled in the report are Agilent Technologies Inc., Fluidigm Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., GE Healthcare, Cepheid Inc., Illumina Inc., and Thermo Fisher Scientific Inc.

RECENT HAPPENINGS IN THIS MARKET:

  • The acquisition of Affymetrix Inc., a leading supplier of cellular and genetic analysis products, was completed by Thermo Fisher Scientific Inc. in 2016. This purchase helped Thermo Fisher improve its bioscience leadership and acquire new genetic analysis strengths to serve medical and applied markets better.
  • Affymetrix (US) and Cytox (UK), an innovative developer of risk assessment and dementia prediction assays, formed a strategic partnership in 2015 to develop and market blood-based genetic assay for risk assessment of Alzheimer's disease. This partnership helped extend the company's offer to the research market for dementia.
  • SEKISUI CHEMICAL CO., LTD. announced in April 2018 that it had acquired Veredus Laboratories Pte. Ltd. The aim will be to develop and extend the company's diagnostic reagent and analyzer products, and Veredus Laboratories' expertise and experience will also be used to construct such a system. This acquisition will support Sekisui chemicals by expanding internationally, providing efficient products, and increasing its product portfolio.
  • Qurin Diagnostics B.V. in April 2019. And the Global Lionix B.V. Announced that they had acquired Surfix B.V.; this merger would improve the business and allow innovation to be taken to the global biomedical market. The company is currently working closely together on the early detection of cancer and has developed a responsive biochip. In technology advancement, Qurin and Lionix will benefit from this transaction, enhancing their role and allowing better service. This merger and acquisition in the biochip field will lead in the future to its business expansion.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 Epidemology             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 Type              

                                5.1.1 Introduction

                                5.1.2 DNA Chips

                                5.1.3 Lab-On-A-Chip

                                5.1.4 Protein Chips

                                5.1.5 Other types

                                5.1.6 Y-o-Y Growth Analysis, By Type

                                5.1.7 Market Attractiveness Analysis, By Type

                                5.1.8 Market Share Analysis, By Type

                5.2 End User      

                                5.2.1 Introduction

                                5.2.2 Hospitals and Diagnostics Centers

                                5.2.3 Biotechnology and Pharmaceutical Companies

                                5.2.4 Academic & Research Institutes

                                5.2.5 Y-o-Y Growth Analysis, By End User

                                5.2.6 Market Attractiveness Analysis, By End User

                                5.2.7 Market Share Analysis, By End User

                5.3 Fabrication Technology         

                                5.3.1 Introduction

                                5.3.2 Microfluidics

                                5.3.3 Microarrays

                                5.3.4 Y-o-Y Growth Analysis, By Fabrication Technology

                                5.3.5 Market Attractiveness Analysis, By Fabrication Technology

                                5.3.6 Market Share Analysis, By Fabrication Technology

6. Geographical Analysis                              

                6.1 Introduction              

                                6.1.1 Regional Trends

                                6.1.2 Impact Analysis

                                6.1.3 Y-o-Y Growth Analysis

                                6.1.4 Market Attractiveness Analysis

                                6.1.5 Market Share Analysis

                6.2 North America          

                                6.1.1 Introduction

                                6.1.2 United States

                                6.1.3 Canada 

                6.3 Europe         

                                6.2.1 Introduction

                                6.2.2 U.K

                                6.2.3 Spain

                                6.2.4 Germany

                                6.2.5 Italy 

                                6.2.6 France

                6.4 Asia-Pacific 

                                6.3.1 Introduction

                                6.3.2 China 

                                6.3.3 India 

                                6.3.4 Japan 

                                6.3.5 Australia

                                6.3.6 South Korea

                6.5 Latin America            

                                6.4.1 Introduction

                                6.4.2 Brazil

                                6.4.3 Argentina

                                6.4.4 Mexico

                                6.4.5 Rest of Latin America

                6.6 Middle East & Africa

                                6.5.1 Introduction

                                6.5.2 Middle-East

                                6.5.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Athersys      

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments

                                8.1.5 SWOT analysis

                                8.1.6 Analyst View

                8.2 StemCells    

                8.3 Cryo Cell International           

                8.4 Geron Corporation  

                8.5 Mesoblast  

                8.6 Aastrom Biosciences               

                8.7 Celgene Corporation              

                8.8 Invitrogen   

                8.9 Cytori Therapeutics

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Market Outlook and Investment Opportunities                           

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Biochips Market, By Region, From 2021 to 2026 (USD Million)
  2. Global Biochips Market, By Type, From 2021 to 2026 (USD Million)
  3. Global DNA Chips Market, By Region, From 2021 to 2026 (USD Million)
  4. Global Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  5. Global SNP Genotyping Market, By Region, From 2021 to 2026 (USD Million)
  6. Global Genomics Market, By Region, From 2021 to 2026 (USD Million)
  7. Global Agricultural Biotechnology Market, By Region, From 2021 to 2026 (USD Million)
  8. Global Gene Expression Market, By Region, From 2021 to 2026 (USD Million)
  9. Global Cancer Diagnosis & Treatment Market, By Region, From 2021 to 2026 (USD Million)
  10. Global Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  11. Global Other DNA chips Market, By Region, From 2021 to 2026 (USD Million)
  12. Global Lab-On-A-Chip Market, By Region, From 2021 to 2026 (USD Million)
  13. Global Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  14. Global Clinical Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  15. Global IVD & POC Market, By Region, From 2021 to 2026 (USD Million)
  16. Global Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  17. Global Genomics Market, By Region, From 2021 to 2026 (USD Million)
  18. Global Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  19. Global Protein Chips Market, By Region, From 2021 to 2026 (USD Million)
  20. Global Other types Market, By Region, From 2021 to 2026 (USD Million)
  21. Global Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  22. Global Expression Profiling Market, By Region, From 2021 to 2026 (USD Million)
  23. Global High-Throughput Screening Market, By Region, From 2021 to 2026 (USD Million)
  24. Global Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  25. Global Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  26. Global Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  27. Global Biochips Market, By End User, From 2021 to 2026 (USD Million)
  28. Global Hospitals and Diagnostics Centers Market, By Region, From 2021 to 2026 (USD Million)
  29. Global Biotechnology and Pharmaceutical Companies Market, By Region, From 2021 to 2026 (USD Million)
  30. Global Academic & Research Institutes Market, By Region, From 2021 to 2026 (USD Million)
  31. Global Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  32. Global Microfluidics Market, By Region, From 2021 to 2026 (USD Million)
  33. Global Microarrays Market, By Region, From 2021 to 2026 (USD Million)
  34. North America Biochips Market, By Region, From 2021 to 2026 (USD Million)
  35. North America Biochips Market, By Type, From 2021 to 2026 (USD Million)
  36. North America DNA Chips Market, By Region, From 2021 to 2026 (USD Million)
  37. North America Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  38. North America SNP Genotyping Market, By Region, From 2021 to 2026 (USD Million)
  39. North America Genomics Market, By Region, From 2021 to 2026 (USD Million)
  40. North America Agricultural Biotechnology Market, By Region, From 2021 to 2026 (USD Million)
  41. North America Gene Expression Market, By Region, From 2021 to 2026 (USD Million)
  42. North America Cancer Diagnosis & Treatment Market, By Region, From 2021 to 2026 (USD Million)
  43. North America Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  44. North America Other DNA chips Market, By Region, From 2021 to 2026 (USD Million)
  45. North America Lab-On-A-Chip Market, By Region, From 2021 to 2026 (USD Million)
  46. North America Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  47. North America Clinical Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  48. North America IVD & POC Market, By Region, From 2021 to 2026 (USD Million)
  49. North America Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  50. North America Genomics Market, By Region, From 2021 to 2026 (USD Million)
  51. North America Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  52. North America Protein Chips Market, By Region, From 2021 to 2026 (USD Million)
  53. North America Other types Market, By Region, From 2021 to 2026 (USD Million)
  54. North America Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  55. North America Expression Profiling Market, By Region, From 2021 to 2026 (USD Million)
  56. North America High-Throughput Screening Market, By Region, From 2021 to 2026 (USD Million)
  57. North America Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  58. North America Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  59. North America Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  60. North America Biochips Market, By End User, From 2021 to 2026 (USD Million)
  61. North America Hospitals and Diagnostics Centers Market, By Region, From 2021 to 2026 (USD Million)
  62. North America Biotechnology and Pharmaceutical Companies Market, By Region, From 2021 to 2026 (USD Million)
  63. North America Academic & Research Institutes Market, By Region, From 2021 to 2026 (USD Million)
  64. North America Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  65. North America Microfluidics Market, By Region, From 2021 to 2026 (USD Million)
  66. North America Microarrays Market, By Region, From 2021 to 2026 (USD Million)
  67. United States Biochips Market, By Type, From 2021 to 2026 (USD Million)
  68. United States Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  69. United States Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  70. United States Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  71. United States Biochips Market, By End User, From 2021 to 2026 (USD Million)
  72. United States Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  73. Canada Biochips Market, By Type, From 2021 to 2026 (USD Million)
  74. Canada Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  75. Canada Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  76. Canada Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  77. Canada Biochips Market, By End User, From 2021 to 2026 (USD Million)
  78. Canada Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  79. Europe Biochips Market, By Region, From 2021 to 2026 (USD Million)
  80. Europe Biochips Market, By Type, From 2021 to 2026 (USD Million)
  81. Europe DNA Chips Market, By Region, From 2021 to 2026 (USD Million)
  82. Europe Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  83. Europe SNP Genotyping Market, By Region, From 2021 to 2026 (USD Million)
  84. Europe Genomics Market, By Region, From 2021 to 2026 (USD Million)
  85. Europe Agricultural Biotechnology Market, By Region, From 2021 to 2026 (USD Million)
  86. Europe Gene Expression Market, By Region, From 2021 to 2026 (USD Million)
  87. Europe Cancer Diagnosis & Treatment Market, By Region, From 2021 to 2026 (USD Million)
  88. Europe Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  89. Europe Other DNA chips Market, By Region, From 2021 to 2026 (USD Million)
  90. Europe Lab-On-A-Chip Market, By Region, From 2021 to 2026 (USD Million)
  91. Europe Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  92. Europe Clinical Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  93. Europe IVD & POC Market, By Region, From 2021 to 2026 (USD Million)
  94. Europe Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  95. Europe Genomics Market, By Region, From 2021 to 2026 (USD Million)
  96. Europe Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  97. Europe Protein Chips Market, By Region, From 2021 to 2026 (USD Million)
  98. Europe Other types Market, By Region, From 2021 to 2026 (USD Million)
  99. Europe Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  100. Europe Expression Profiling Market, By Region, From 2021 to 2026 (USD Million)
  101. Europe High-Throughput Screening Market, By Region, From 2021 to 2026 (USD Million)
  102. Europe Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  103. Europe Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  104. Europe Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  105. Europe Biochips Market, By End User, From 2021 to 2026 (USD Million)
  106. Europe Hospitals and Diagnostics Centers Market, By Region, From 2021 to 2026 (USD Million)
  107. Europe Biotechnology and Pharmaceutical Companies Market, By Region, From 2021 to 2026 (USD Million)
  108. Europe Academic & Research Institutes Market, By Region, From 2021 to 2026 (USD Million)
  109. Europe Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  110. Europe Microfluidics Market, By Region, From 2021 to 2026 (USD Million)
  111. Europe Microarrays Market, By Region, From 2021 to 2026 (USD Million)
  112. U.K Biochips Market, By Type, From 2021 to 2026 (USD Million)
  113. U.K Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  114. U.K Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  115. U.K Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  116. U.K Biochips Market, By End User, From 2021 to 2026 (USD Million)
  117. U.K Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  118. Spain Biochips Market, By Type, From 2021 to 2026 (USD Million)
  119. Spain Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  120. Spain Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  121. Spain Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  122. Spain Biochips Market, By End User, From 2021 to 2026 (USD Million)
  123. Spain Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  124. Germany Biochips Market, By Type, From 2021 to 2026 (USD Million)
  125. Germany Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  126. Germany Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  127. Germany Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  128. Germany Biochips Market, By End User, From 2021 to 2026 (USD Million)
  129. Germany Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  130. Italy Biochips Market, By Type, From 2021 to 2026 (USD Million)
  131. Italy Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  132. Italy Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  133. Italy Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  134. Italy Biochips Market, By End User, From 2021 to 2026 (USD Million)
  135. Italy Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  136. France Biochips Market, By Type, From 2021 to 2026 (USD Million)
  137. France Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  138. France Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  139. France Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  140. France Biochips Market, By End User, From 2021 to 2026 (USD Million)
  141. France Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  142. Asia-Pacific Biochips Market, By Region, From 2021 to 2026 (USD Million)
  143. Asia-Pacific Biochips Market, By Type, From 2021 to 2026 (USD Million)
  144. Asia-Pacific DNA Chips Market, By Region, From 2021 to 2026 (USD Million)
  145. Asia-Pacific Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  146. Asia-Pacific SNP Genotyping Market, By Region, From 2021 to 2026 (USD Million)
  147. Asia-Pacific Genomics Market, By Region, From 2021 to 2026 (USD Million)
  148. Asia-Pacific Agricultural Biotechnology Market, By Region, From 2021 to 2026 (USD Million)
  149. Asia-Pacific Gene Expression Market, By Region, From 2021 to 2026 (USD Million)
  150. Asia-Pacific Cancer Diagnosis & Treatment Market, By Region, From 2021 to 2026 (USD Million)
  151. Asia-Pacific Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  152. Asia-Pacific Other DNA chips Market, By Region, From 2021 to 2026 (USD Million)
  153. Asia-Pacific Lab-On-A-Chip Market, By Region, From 2021 to 2026 (USD Million)
  154. Asia-Pacific Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  155. Asia-Pacific Clinical Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  156. Asia-Pacific IVD & POC Market, By Region, From 2021 to 2026 (USD Million)
  157. Asia-Pacific Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  158. Asia-Pacific Genomics Market, By Region, From 2021 to 2026 (USD Million)
  159. Asia-Pacific Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  160. Asia-Pacific Protein Chips Market, By Region, From 2021 to 2026 (USD Million)
  161. Asia-Pacific Other types Market, By Region, From 2021 to 2026 (USD Million)
  162. Asia-Pacific Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  163. Asia-Pacific Expression Profiling Market, By Region, From 2021 to 2026 (USD Million)
  164. Asia-Pacific High-Throughput Screening Market, By Region, From 2021 to 2026 (USD Million)
  165. Asia-Pacific Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  166. Asia-Pacific Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  167. Asia-Pacific Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  168. Asia-Pacific Biochips Market, By End User, From 2021 to 2026 (USD Million)
  169. Asia-Pacific Hospitals and Diagnostics Centers Market, By Region, From 2021 to 2026 (USD Million)
  170. Asia-Pacific Biotechnology and Pharmaceutical Companies Market, By Region, From 2021 to 2026 (USD Million)
  171. Asia-Pacific Academic & Research Institutes Market, By Region, From 2021 to 2026 (USD Million)
  172. Asia-Pacific Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  173. Asia-Pacific Microfluidics Market, By Region, From 2021 to 2026 (USD Million)
  174. Asia-Pacific Microarrays Market, By Region, From 2021 to 2026 (USD Million)
  175. China Biochips Market, By Type, From 2021 to 2026 (USD Million)
  176. China Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  177. China Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  178. China Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  179. China Biochips Market, By End User, From 2021 to 2026 (USD Million)
  180. China Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  181. India Biochips Market, By Type, From 2021 to 2026 (USD Million)
  182. India Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  183. India Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  184. India Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  185. India Biochips Market, By End User, From 2021 to 2026 (USD Million)
  186. India Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  187. Japan Biochips Market, By Type, From 2021 to 2026 (USD Million)
  188. Japan Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  189. Japan Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  190. Japan Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  191. Japan Biochips Market, By End User, From 2021 to 2026 (USD Million)
  192. Japan Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  193. South Korea Biochips Market, By Type, From 2021 to 2026 (USD Million)
  194. South Korea Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  195. South Korea Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  196. South Korea Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  197. South Korea Biochips Market, By End User, From 2021 to 2026 (USD Million)
  198. South Korea Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  199. Australia Biochips Market, By Type, From 2021 to 2026 (USD Million)
  200. Australia Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  201. Australia Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  202. Australia Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  203. Australia Biochips Market, By End User, From 2021 to 2026 (USD Million)
  204. Australia Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  205. Latin America Biochips Market, By Region, From 2021 to 2026 (USD Million)
  206. Latin America Biochips Market, By Type, From 2021 to 2026 (USD Million)
  207. Latin America DNA Chips Market, By Region, From 2021 to 2026 (USD Million)
  208. Latin America Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  209. Latin America SNP Genotyping Market, By Region, From 2021 to 2026 (USD Million)
  210. Latin America Genomics Market, By Region, From 2021 to 2026 (USD Million)
  211. Latin America Agricultural Biotechnology Market, By Region, From 2021 to 2026 (USD Million)
  212. Latin America Gene Expression Market, By Region, From 2021 to 2026 (USD Million)
  213. Latin America Cancer Diagnosis & Treatment Market, By Region, From 2021 to 2026 (USD Million)
  214. Latin America Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  215. Latin America Other DNA chips Market, By Region, From 2021 to 2026 (USD Million)
  216. Latin America Lab-On-A-Chip Market, By Region, From 2021 to 2026 (USD Million)
  217. Latin America Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  218. Latin America Clinical Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  219. Latin America IVD & POC Market, By Region, From 2021 to 2026 (USD Million)
  220. Latin America Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  221. Latin America Genomics Market, By Region, From 2021 to 2026 (USD Million)
  222. Latin America Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  223. Latin America Protein Chips Market, By Region, From 2021 to 2026 (USD Million)
  224. Latin America Other types Market, By Region, From 2021 to 2026 (USD Million)
  225. Latin America Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  226. Latin America Expression Profiling Market, By Region, From 2021 to 2026 (USD Million)
  227. Latin America High-Throughput Screening Market, By Region, From 2021 to 2026 (USD Million)
  228. Latin America Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  229. Latin America Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  230. Latin America Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  231. Latin America Biochips Market, By End User, From 2021 to 2026 (USD Million)
  232. Latin America Hospitals and Diagnostics Centers Market, By Region, From 2021 to 2026 (USD Million)
  233. Latin America Biotechnology and Pharmaceutical Companies Market, By Region, From 2021 to 2026 (USD Million)
  234. Latin America Academic & Research Institutes Market, By Region, From 2021 to 2026 (USD Million)
  235. Latin America Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  236. Latin America Microfluidics Market, By Region, From 2021 to 2026 (USD Million)
  237. Latin America Microarrays Market, By Region, From 2021 to 2026 (USD Million)
  238. Brazil Biochips Market, By Type, From 2021 to 2026 (USD Million)
  239. Brazil Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  240. Brazil Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  241. Brazil Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  242. Brazil Biochips Market, By End User, From 2021 to 2026 (USD Million)
  243. Brazil Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  244. Argentina Biochips Market, By Type, From 2021 to 2026 (USD Million)
  245. Argentina Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  246. Argentina Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  247. Argentina Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  248. Argentina Biochips Market, By End User, From 2021 to 2026 (USD Million)
  249. Argentina Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  250. Mexico Biochips Market, By Type, From 2021 to 2026 (USD Million)
  251. Mexico Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  252. Mexico Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  253. Mexico Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  254. Mexico Biochips Market, By End User, From 2021 to 2026 (USD Million)
  255. Mexico Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  256. Rest of Latin America Biochips Market, By Type, From 2021 to 2026 (USD Million)
  257. Rest of Latin America Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  258. Rest of Latin America Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  259. Rest of Latin America Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  260. Rest of Latin America Biochips Market, By End User, From 2021 to 2026 (USD Million)
  261. Rest of Latin America Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  262. Middle East & Africa Biochips Market, By Region, From 2021 to 2026 (USD Million)
  263. Middle East & Africa Biochips Market, By Type, From 2021 to 2026 (USD Million)
  264. Middle East & Africa DNA Chips Market, By Region, From 2021 to 2026 (USD Million)
  265. Middle East & Africa Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  266. Middle East & Africa SNP Genotyping Market, By Region, From 2021 to 2026 (USD Million)
  267. Middle East & Africa Genomics Market, By Region, From 2021 to 2026 (USD Million)
  268. Middle East & Africa Agricultural Biotechnology Market, By Region, From 2021 to 2026 (USD Million)
  269. Middle East & Africa Gene Expression Market, By Region, From 2021 to 2026 (USD Million)
  270. Middle East & Africa Cancer Diagnosis & Treatment Market, By Region, From 2021 to 2026 (USD Million)
  271. Middle East & Africa Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  272. Middle East & Africa Other DNA chips Market, By Region, From 2021 to 2026 (USD Million)
  273. Middle East & Africa Lab-On-A-Chip Market, By Region, From 2021 to 2026 (USD Million)
  274. Middle East & Africa Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  275. Middle East & Africa Clinical Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  276. Middle East & Africa IVD & POC Market, By Region, From 2021 to 2026 (USD Million)
  277. Middle East & Africa Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  278. Middle East & Africa Genomics Market, By Region, From 2021 to 2026 (USD Million)
  279. Middle East & Africa Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  280. Middle East & Africa Protein Chips Market, By Region, From 2021 to 2026 (USD Million)
  281. Middle East & Africa Other types Market, By Region, From 2021 to 2026 (USD Million)
  282. Middle East & Africa Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  283. Middle East & Africa Expression Profiling Market, By Region, From 2021 to 2026 (USD Million)
  284. Middle East & Africa High-Throughput Screening Market, By Region, From 2021 to 2026 (USD Million)
  285. Middle East & Africa Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  286. Middle East & Africa Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  287. Middle East & Africa Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  288. Middle East & Africa Biochips Market, By End User, From 2021 to 2026 (USD Million)
  289. Middle East & Africa Hospitals and Diagnostics Centers Market, By Region, From 2021 to 2026 (USD Million)
  290. Middle East & Africa Biotechnology and Pharmaceutical Companies Market, By Region, From 2021 to 2026 (USD Million)
  291. Middle East & Africa Academic & Research Institutes Market, By Region, From 2021 to 2026 (USD Million)
  292. Middle East & Africa Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  293. Middle East & Africa Microfluidics Market, By Region, From 2021 to 2026 (USD Million)
  294. Middle East & Africa Microarrays Market, By Region, From 2021 to 2026 (USD Million)
  295. Middle East Biochips Market, By Type, From 2021 to 2026 (USD Million)
  296. Middle East Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  297. Middle East Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  298. Middle East Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  299. Middle East Biochips Market, By End User, From 2021 to 2026 (USD Million)
  300. Middle East Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)
  301. Africa Biochips Market, By Type, From 2021 to 2026 (USD Million)
  302. Africa Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  303. Africa Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  304. Africa Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  305. Africa Biochips Market, By End User, From 2021 to 2026 (USD Million)
  306. Africa Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample